BofA upgraded Revolution Medicines to Buy from Neutral with a $34 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RVMD:
- Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference
- Largest borrow rate increases among liquid names
- Revolution Medicines initiated with an Outperform at Raymond James
- Revolution Medicines price target lowered to $28 from $32 at H.C. Wainwright
- Revolution Medicines announces Horning joined board of directors